Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001104659-25-003440
Filing Date
2025-01-14
Accepted
2025-01-14 16:06:02
Documents
5
Period of Report
2025-01-10

Document Format Files

Seq Description Document Type Size
1 PREM14A tm2429853-6_prem14a.htm PREM14A 3218292
2 EX-FILING FEES tm2429853d7_ex-filingfees.htm EX-FILING FEES 10349
3 GRAPHIC lg_coherus-4c.jpg GRAPHIC 22532
4 GRAPHIC lg_jpmorgan-bwlr.jpg GRAPHIC 8545
5 GRAPHIC lg_sodali-4c.jpg GRAPHIC 9173
  Complete submission text file 0001104659-25-003440.txt   3285736
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

EIN.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREM14A | Act: 34 | File No.: 001-36721 | Film No.: 25529445
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)